Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019
Soliton, Inc. (SOLY)
Company Research
Source: PR Newswire
HOUSTON, Sept. 24, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has surpassed 75% of the required patients to be treated in its pivotal cellulite trial.More than 75% of the 60 required prospective patients have been successfully treated across the four clinical sites in the pivotal trial.Join our more than 200K fans here to follow the Company: https://soly-investors.comDr. Chris Capelli, President, CEO and co-founder of Soliton, commented, "We are greatly encouraged by the progress of our cellulite trials. We look forward to continued execution and providing results upon completion." Dr. Capelli continued, "We expect the results of this study to form the basis of our application with the FDA for clearance in cellulite reduction and hope to be filing th
Show less
Read more
Impact Snapshot
Event Time:
SOLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOLY alerts
High impacting Soliton, Inc. news events
Weekly update
A roundup of the hottest topics